FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

View source ↗

Summary

FDA authorized the first wearable that continuously monitors both ketone levels and blood glucose for people with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System

Snippet

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.